Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Generation Bio CO (GBIO)

Generation Bio CO (GBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,231,223
  • Shares Outstanding, K 56,634
  • Annual Sales, $ 0 K
  • Annual Income, $ -80,520 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.60
Trade GBIO with:

Options Overview

Details
  • Implied Volatility 70.12%
  • Historical Volatility 63.64%
  • IV Percentile 71%
  • IV Rank 47.39%
  • IV High 98.06% on 03/22/21
  • IV Low 44.96% on 07/28/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 86
  • Open Int (30-Day) 701

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.47
  • Number of Estimates 5
  • High Estimate -0.43
  • Low Estimate -0.50
  • Prior Year -1.50
  • Growth Rate Est. (year over year) +68.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.16 +13.50%
on 07/15/21
27.99 -22.33%
on 07/01/21
-5.16 (-19.18%)
since 06/30/21
3-Month
19.16 +13.50%
on 07/15/21
36.72 -40.80%
on 05/03/21
-14.72 (-40.37%)
since 04/30/21
52-Week
18.80 +15.64%
on 08/04/20
55.72 -60.98%
on 12/02/20
+1.60 (+7.94%)
since 07/30/20

Most Recent Stories

More News
GBIO Crosses Above Average Analyst Target

In recent trading, shares of Generation Bio Co have crossed above the average analyst 12-month target price of $39.25, changing hands for $40.20/share. When a stock reaches the target an analyst has...

GBIO : 21.74 (+3.03%)
Why Earnings Season Could Be Great for Generation Bio (GBIO)

Generation Bio (GBIO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

GBIO : 21.74 (+3.03%)
Generation Bio Appoints Ron Cooper to Its Board of Directors

Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, announced today that Ron Cooper has been appointed to its Board of Directors. The appointment...

ALBO : 28.61 (-2.39%)
GBIO : 21.74 (+3.03%)
Generation Bio (GBIO) Catches Eye: Stock Jumps 6.1%

Generation Bio (GBIO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

HALO : 41.33 (+0.63%)
GBIO : 21.74 (+3.03%)
Generation Bio to Present at 39th Annual J.P. Morgan Healthcare Conference

Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that the company will present at the virtual 39 Annual J.P. Morgan...

JPM : 151.78 (-0.80%)
GBIO : 21.74 (+3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 23.49
2nd Resistance Point 22.79
1st Resistance Point 22.26
Last Price 21.74
1st Support Level 21.04
2nd Support Level 20.34
3rd Support Level 19.81

See More

52-Week High 55.72
Fibonacci 61.8% 41.62
Fibonacci 50% 37.26
Fibonacci 38.2% 32.90
Last Price 21.74
52-Week Low 18.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar